Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C GALE

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Experimental Eye Research|March 15, 2011
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical modelsAchim H P Krauss, Francesco Impagnatiello, Carol B Toris, et al.
International Journal of Obesity (2005)|January 24, 2015
Sexual dimorphism in relation to adipose tissue and intrahepatocellular lipid deposition in early infancyC Gale, K M Logan, S Jeffries, et al.
ACS Nano|January 12, 2024
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 VaccinesBen S Ou, Julie Baillet, Vittoria C T M Picece, et al.
Anti-Cancer Drugs|August 1, 1993
XB596, a promising bis-naphthalimide anti-cancer agentS F Chen, D L Behrens, C H Behrens, et al.
Experimental Eye Research|March 2, 2011
A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogsF Impagnatiello, V Borghi, D C Gale, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
JAMA Surgery|January 3, 2020
Palliative Care and End-of-Life Outcomes Following High-risk SurgeryMaria Yefimova, Rebecca A Aslakson, Lingyao Yang, et al.
Journal of Biomedical Materials Research. Part A|May 6, 2021
Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunityOlivia M Saouaf, Gillie A Roth, Ben S Ou, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2009
Synthesis of novel nitric oxide (NO)-releasing esters of timololValerio Chiroli, Minerva R Batugo, Stefano Biondi, et al.
Implementation Science : IS|February 26, 2016
The facilitators and barriers associated with implementation of a patient-centered medical home in VHAChristian D Helfrich, Philip W Sylling, Randall C Gale, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Experimental Eye Research|March 15, 2011
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical modelsAchim H P Krauss, Francesco Impagnatiello, Carol B Toris, et al.
International Journal of Obesity (2005)|January 24, 2015
Sexual dimorphism in relation to adipose tissue and intrahepatocellular lipid deposition in early infancyC Gale, K M Logan, S Jeffries, et al.
ACS Nano|January 12, 2024
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 VaccinesBen S Ou, Julie Baillet, Vittoria C T M Picece, et al.
Anti-Cancer Drugs|August 1, 1993
XB596, a promising bis-naphthalimide anti-cancer agentS F Chen, D L Behrens, C H Behrens, et al.
Experimental Eye Research|March 2, 2011
A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogsF Impagnatiello, V Borghi, D C Gale, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
JAMA Surgery|January 3, 2020
Palliative Care and End-of-Life Outcomes Following High-risk SurgeryMaria Yefimova, Rebecca A Aslakson, Lingyao Yang, et al.
Journal of Biomedical Materials Research. Part A|May 6, 2021
Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunityOlivia M Saouaf, Gillie A Roth, Ben S Ou, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2009
Synthesis of novel nitric oxide (NO)-releasing esters of timololValerio Chiroli, Minerva R Batugo, Stefano Biondi, et al.
Implementation Science : IS|February 26, 2016
The facilitators and barriers associated with implementation of a patient-centered medical home in VHAChristian D Helfrich, Philip W Sylling, Randall C Gale, et al.
Pageof 19